These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18783305)

  • 1. Exemestane-induced subclinical hypothyroidism : a case report.
    Mazokopakis EE; Karefilakis CM; Tsartsalis AN; Milkas AN; Starakis IK
    Clin Drug Investig; 2008; 28(10):669-71. PubMed ID: 18783305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.
    Laurberg P; Andersen S; Bülow Pedersen I; Carlé A
    Drugs Aging; 2005; 22(1):23-38. PubMed ID: 15663347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exemestane: a milestone against breast cancer.
    Shetty YC; Chakkarwar PN; Acharya SS; Rajadhyaksha VD
    J Postgrad Med; 2007; 53(2):135-8. PubMed ID: 17495383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exemestane induced cholestatic liver injury - A case report.
    Fritzsche D; Indorf A; Miske A; Banda K
    J Oncol Pharm Pract; 2021 Jun; 27(4):1029-1032. PubMed ID: 32951520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug safety evaluation of exemestane.
    Lintermans A; Neven P; Paridaens R
    Expert Opin Drug Saf; 2011 May; 10(3):473-87. PubMed ID: 21428848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with exemestane in the treatment of early and advanced breast cancer.
    Lønning PE; Geisler J
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):987-97. PubMed ID: 18624685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothyroidism in adults. Levothyroxine if warranted by clinical and laboratory findings, not for simple TSH elevation.
    Prescrire Int; 2015 Oct; 24(164):241-4, 246. PubMed ID: 26594730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical hypothyroidism: Should we treat?
    Redford C; Vaidya B
    Post Reprod Health; 2017 Jun; 23(2):55-62. PubMed ID: 28406057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors in the breast cancer clinic: focus on exemestane.
    Van Asten K; Neven P; Lintermans A; Wildiers H; Paridaens R
    Endocr Relat Cancer; 2014 Feb; 21(1):R31-49. PubMed ID: 24434719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficulties in diagnosing and managing coexisting primary hypothyroidism and resistance to thyroid hormone.
    Tran HA
    Endocr Pract; 2006; 12(3):288-93. PubMed ID: 16772202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over.
    Du Puy RS; Postmus I; Stott DJ; Blum MR; Poortvliet RKE; Den Elzen WPJ; Peeters RP; van Munster BC; Wolffenbuttel BHR; Westendorp RGJ; Kearney PM; Ford I; Kean S; Messow CM; Watt T; Jukema JW; Dekkers OM; Smit JWA; Rodondi N; Gussekloo J; Mooijaart SP
    BMC Endocr Disord; 2018 Sep; 18(1):67. PubMed ID: 30231866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of exemestane in the Intergroup Exemestane Study.
    Coombes RC; Bliss JM; Hall E
    J Clin Oncol; 2005 May; 23(13):3171-2. PubMed ID: 15860896
    [No Abstract]   [Full Text] [Related]  

  • 13. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
    Mieog JS; Morden JP; Bliss JM; Coombes RC; van de Velde CJ;
    Lancet Oncol; 2012 Apr; 13(4):420-32. PubMed ID: 22265698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
    Coombes RC; Kilburn LS; Snowdon CF; Paridaens R; Coleman RE; Jones SE; Jassem J; Van de Velde CJ; Delozier T; Alvarez I; Del Mastro L; Ortmann O; Diedrich K; Coates AS; Bajetta E; Holmberg SB; Dodwell D; Mickiewicz E; Andersen J; Lønning PE; Cocconi G; Forbes J; Castiglione M; Stuart N; Stewart A; Fallowfield LJ; Bertelli G; Hall E; Bogle RG; Carpentieri M; Colajori E; Subar M; Ireland E; Bliss JM;
    Lancet; 2007 Feb; 369(9561):559-70. PubMed ID: 17307102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exemestane in postmenopausal women with early or advanced breast cancer: a review.
    Bertelli G; Gangadhara S
    Expert Opin Pharmacother; 2010 Aug; 11(11):1933-42. PubMed ID: 20569090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exemestane for breast-cancer prevention in postmenopausal women.
    Goss PE; Ingle JN; Alés-Martínez JE; Cheung AM; Chlebowski RT; Wactawski-Wende J; McTiernan A; Robbins J; Johnson KC; Martin LW; Winquist E; Sarto GE; Garber JE; Fabian CJ; Pujol P; Maunsell E; Farmer P; Gelmon KA; Tu D; Richardson H;
    N Engl J Med; 2011 Jun; 364(25):2381-91. PubMed ID: 21639806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution with thyroid hormones in the elderly : Goals and risks].
    von Werder A; von Werder K
    Internist (Berl); 2018 Oct; 59(10):1114-1118. PubMed ID: 29995250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Levothyroxine Therapy on the Development of Depressive Symptoms in Older Adults With Subclinical Hypothyroidism: An Ancillary Study of a Randomized Clinical Trial.
    Wildisen L; Feller M; Del Giovane C; Moutzouri E; Du Puy RS; Mooijaart SP; Collet TH; Poortvliet RKE; Kearney P; Quinn TJ; Klöppel S; Bauer DC; Peeters RP; Westendorp R; Aujesky D; Gussekloo J; Rodondi N
    JAMA Netw Open; 2021 Feb; 4(2):e2036645. PubMed ID: 33566107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Stimulating Hormone Level at Diagnosis as a Predictor of Persistent Subclinical Hypothyroidism in Children with Down Syndrome.
    Sankar HV; Anjukrishna K; Riaz I
    Indian Pediatr; 2018 Jul; 55(7):576-578. PubMed ID: 30129539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
    Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
    Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.